GlassScriptPhysician profile
Lisa D Beasley
NPI 1003117656
$2,324.78
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $957 · 2022: $635 · 2023: $691 · 2024: $41.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $648.62 | 2021-2023 | Austedo Xr, Austedo |
| Astrazeneca Pharmaceuticals LP | $339.14 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $198.37 | 2022 | |
| Abbott Laboratories | $154.26 | 2022 | |
| Nevro Corp. | $134.76 | 2023 | Senza |
| Alexion Pharmaceuticals, INC. | $121.72 | 2021 | |
| Novo Nordisk INC | $114.46 | 2022 | |
| Urovant Sciences INC | $112.42 | 2021 | |
| Xeris Pharmaceuticals, INC. | $111.14 | 2023 | Gvoke Hypopen |
| Bioxcel Therapeutics, INC. | $110.29 | 2023 | Igalmi |
| Horizon Therapeutics Plc | $103.80 | 2023 | Krystexxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.24 | 2022 | |
| Organon LLC | $41.21 | 2024 | |
| Boston Scientific Corporation | $24.35 | 2023 | |
| Mckesson Medical-Surgical, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.